NewcelX Publishes Peer-Reviewed Study Demonstrating Broad Therapeutic Potential of its Stem Cell Technology Platform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. INFY
4. RNG
5. AMD
6. URI
7. EW
8. GRC
9. INFO:IN
10. COLB

Go back to NewcelX Publishes Peer-Reviewed Study Demonstrating Broad Therapeutic Potential of its Stem Cell Technology Platform
(NASDAQ: NCEL) Delayed: 3.80 --0 (-0%)
Previous Close $3.80    52 Week High $ 
Open $3.80    52 Week Low $ 
Day High $3.80    P/E N/A 
Day Low $3.80    EPS $ 
Volume 1,363